Latest from PacerMonitor
|
Tue 8/15/2023
-- by Juliette Fairley
A Danish pharmaceutical company is the only business in the U.S. with Food and Drug Administration (FDA) approval to market semaglutide drugs, but that hasn't stopped certain healthcare providers from allegedly selling counterfeit versions.
Novo Nordisk filed five federal lawsuits in New York, Texas, Tennessee and Florida complaining that compounding pharmacies, med spas and diet clinics illegally sold unapproved versions of their popular weight loss and Type 2 diabetes drugs to their customers.
Wegovy and Ozempic both have semaglutide as an ingredient.
"At higher amounts, it increases your sense of satiation so you feel full, and once you feel full, you're not eating, and therefore that could lead to weight loss," said Reuben Saba, vice president of medical and business affairs at Medicure.....
|
|||
|
Thu 7/20/2023
-- by Juliette Fairley
A popular credit repair company filed for chapter 11 bankruptcy after losing litigation lodged by the federal Consumer Financial Protection Bureau (CFPB) over its business model.
The voluntary petition was submitted June 4 under PGX Holdings in the U.S. Bankruptcy Court for the District of Delaware with up to $500 million in listed assets, up to $10 billion in liabilities and more than 100,000 creditors.
"Like most major companies that file chapter 11, they will find ways to continue doing business, and hopefully in a more ethical manner," said Derek Jacques, a bankruptcy attorney with The Mitten Law Firm in Michigan. "I found the whole case interesting as I think there are a lot of bad actors in the debt repair space, and these were the biggest among them."....
|
|||
|
More from PacerMonitor |
News